BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14601016)

  • 1. A competing-risks nomogram for sarcoma-specific death following local recurrence.
    Kattan MW; Heller G; Brennan MF
    Stat Med; 2003 Nov; 22(22):3515-25. PubMed ID: 14601016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
    Mariani L; Miceli R; Kattan MW; Brennan MF; Colecchia M; Fiore M; Casali PG; Gronchi A
    Cancer; 2005 Jan; 103(2):402-8. PubMed ID: 15578681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
    Tai BC; Machin D; White I; Gebski V;
    Stat Med; 2001 Mar; 20(5):661-84. PubMed ID: 11241570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE.
    Mitchell JA; Cooperberg MR; Elkin EP; Lubeck DP; Mehta SS; Kane CJ; Carroll PR
    J Urol; 2005 Apr; 173(4):1126-31. PubMed ID: 15758720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Suardi N; Porter CR; Reuther AM; Walz J; Kodama K; Gibbons RP; Correa R; Montorsi F; Graefen M; Huland H; Klein EA; Karakiewicz PI
    Cancer; 2008 Mar; 112(6):1254-63. PubMed ID: 18286530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution.
    Gronchi A; Casali PG; Fiore M; Mariani L; Lo Vullo S; Bertulli R; Colecchia M; Lozza L; Olmi P; Santinami M; Rosai J
    Cancer; 2004 Jun; 100(11):2448-55. PubMed ID: 15160351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
    Sorbellini M; Kattan MW; Snyder ME; Reuter V; Motzer R; Goetzl M; McKiernan J; Russo P
    J Urol; 2005 Jan; 173(1):48-51. PubMed ID: 15592023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality.
    Eilber FC; Brennan MF; Eilber FR; Dry SM; Singer S; Kattan MW
    Cancer; 2004 Nov; 101(10):2270-5. PubMed ID: 15484214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients.
    Hupertan V; Roupret M; Poisson JF; Chretien Y; Dufour B; Thiounn N; Mejean A
    Cancer; 2006 Dec; 107(11):2604-8. PubMed ID: 17075871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exactitude of relative survival compared with cause-specific survival and competing risk estimations based on a clinical database of patients with colorectal carcinoma.
    Stelzner S; Hellmich G; Koch R; Witzigmann H
    Dis Colon Rectum; 2009 Jul; 52(7):1264-71. PubMed ID: 19571703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of follow-up timing from study of patterns of first failure after primary treatment. An example from patients with NSCLC: a study of the REACT working group of ESTRO.
    Ataman OU; Barrett A; Filleron T; Kramar A;
    Radiother Oncol; 2006 Jan; 78(1):95-100. PubMed ID: 16256232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining high risk prostate cancer with risk groups and nomograms: implications for designing clinical trials.
    Roach M; Weinberg V; Nash M; Sandler HM; McLaughlin PW; Kattan MW
    J Urol; 2006 Dec; 176(6 Pt 2):S16-20. PubMed ID: 17084158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.
    Rosthøj S; Andersen PK; Abildstrom SZ
    Comput Methods Programs Biomed; 2004 Apr; 74(1):69-75. PubMed ID: 14992828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
    Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
    Alektiar KM; Brennan MF; Healey JH; Singer S
    J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.